Sleep Medicine
Volume 10, Issue 10 , Pages 1155-1157, December 2009

The dopaminergic neurons of the A11 system in RLS autopsy brains appear normal

  • Christopher J. Earley

      Affiliations

    • Department of Neurology, Johns Hopkins University, Johns Hopkins Bayview Medical Center, 5501 Hopkins Bayview Circle, AAC 1B-82, Baltimore, MD 21224, USA
    • Corresponding Author InformationCorresponding author. Tel.: +1 410 550 1044; fax: +1 410 550 3364.
  • ,
  • Richard P. Allen

      Affiliations

    • Department of Neurology, Johns Hopkins University, Johns Hopkins Bayview Medical Center, 5501 Hopkins Bayview Circle, AAC 1B-82, Baltimore, MD 21224, USA
  • ,
  • James R. Connor

      Affiliations

    • Department of Neurosurgery, Penn State College of Medicine, Hershey, PA, USA
  • ,
  • Luigi Ferrucci

      Affiliations

    • NIH/NIA, Baltimore Longitudinal Study on Aging, Baltimore, MD, USA
  • ,
  • Juan Troncoso

      Affiliations

    • Department of Pathology, Johns Hopkins University, Baltimore, MD, USA

Received 18 December 2008; received in revised form 26 January 2009; accepted 29 January 2009.

Abstract 

Although the positive clinical benefits of levodopa have fostered the concept of an abnormality in the dopaminergic system in Restless Legs Syndrome (RLS), research into the nigro–striatal (PET/SPECT studies) or tubero-infundibular (i.e., prolactin secretion) dopaminergic pathways has shown limited positive results. Some research groups have focused on the A11 dopaminergic system in the hypothalamus as this is the primary source of descending dopaminergic input into the spinal cord, an area of the nervous system believed by some investigators to be involved in RLS symptom development. Some investigators have now proposed lesioning or toxin-inhibiting the A11 system as a model of RLS, even though there has been no clear clinical or autopsy data to suggest that RLS is a neurodegenerative disorder. In this study, the A11 cell bodies were identified in 6 RLS and 6 aged-matched control autopsy cases. Cells were stained for tyrosine hydroxylase (TH), and stereological measure of the individual TH (+) cell volume was made. Regional assessment of gliosis as assessed by immunostaining for glial fibrillary acidic protein (GFAP) was made in the surrounding tissue. General histological staining was also performed on the tissue. This study found no significant difference between RLS or control cases on any measure used: TH (+) cell volume, fractional GFAP staining, or general histological examination. Nor was there histological indication of any significant inflammation or concurrent ongoing pathology in these RLS cases. The findings do not support the concept of dramatic cell loss or of a neurodegenerative process in the A11 hypothalamic region of patients with RLS. However, that does not exclude the possibility that the A11 system is involved in RLS symptoms. Changes at the cellular level in dopaminergic metabolism or at the distal synapse with changes in receptors or transporters were not evaluated in this study.

Keywords: Restless Legs Syndrome, A11 dopaminergic system, Hypothalamus, Tyrosine hydroxylase, Gliosis, Hypothalamus, Human autopsy, Brain

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S1389-9457(09)00050-1

doi:10.1016/j.sleep.2009.01.006

Sleep Medicine
Volume 10, Issue 10 , Pages 1155-1157, December 2009